SASH1 and cancer: Specifically, SASH1-deficient cancer cells may, through paracrine mechanisms such as secreting cytokines like TGF-β, activate adjacent fibroblasts, inducing their transformation into pro-tumorigenic cancer-associated fibroblasts (CAFs)[27,28].